Skip to main content
. 2022 Nov 17;270(3):1466–1477. doi: 10.1007/s00415-022-11442-y

Table 1.

Demographics, clinical scores and frequency of motor symptoms for all mutation carriers (C9orf72, GRN, MAPT) and healthy controls

Controls All mutation carriers C9orf72 GRN MAPT
CDR® plus NACC FTLD All 0 0.5 1 +  All 0 0.5 1 +  All 0 0.5 1 +  All 0 0.5 1 + 
Number of participants 310 522 291 82 149 221 112 37 72 213 130 31 52 88 49 14 25
% Male 44 44 38 41 58 49 41 41 65 39 35 48 46 45 41 29 64
Age (years) 46.0 (12.7) 50.1 (13.7) 44.2 (11.9) 49.7 (12.3) 62.0 (9.2) 51.2 (13.6) 44.5 (11.7) 49.4 (11.2) 62.7 (9.3) 51.0 (13.6) 45.8 (12.2) 51.8 (13.2) 63.5 (7.7) 45.3 (13.1) 39.2 (10.4) 45.7 (12.6) 57.0 (10.1)
Education (years) 14.5 (3.3) 13.9 (3.4) 14.5 (3.2) 13.9 (3.1) 12.8 (3.7) 13.9 (3.2) 14.4 (3.0) 14.1 (2.6) 13.1 (3.7) 13.9 (3.7) 14.7 (3.4) 14.0 (4.0) 11.9 (3.5) 14.1 (3.3) 14.4 (3.3) 13.5 (2.4) 13.6 (3.8)
MMSE 29.3 (1.0) 27.1 (5.3) 29.3 (1.0) 28.5 (2.2) 21.9 (7.6) 27.2 (4.7) 29.1 (1.2) 28.5 (2.1) 23.4 (6.6) 26.9 (6.0) 29.4 (0.9) 28.5 (2.4) 19.3 (8.4) 27.4 (5.1) 29.5 (0.8) 28.2 (2.3) 22.8 (7.7)
CDR® plus NACC FTLD Global score 0.1 (0.2) 0.6 (1.0) 0.0 (0.0) 0.5 (0.0) 2.0 (0.8) 0.8 (1.0) 0.0 (0.0) 0.5 (0.0) 2.1 (0.8) 0.5 (0.9) 0.0 (0.0) 0.5 (0.0) 1.9 (0.8) 0.6 (0.9) 0.0 (0.0) 0.5 (0.0) 1.9 (0.8)
CDR® plus NACC FTLD Sum of Boxes 0.2 (0.4) 3.1 (5.5) 0.0 (0.0) 1.1 (0.8) 10.3 (5.8) 3.8 (6.0) 0.0 (0.0) 1.1 (0.8) 10.9 (5.7) 2.5 (5.1) 0.0 (0.0) 1.0 (0.8) 9.8 (6.0) 2.9 (5.3) 0.0 (0.0) 1.1 (0.8) 9.7 (5.8)
Motor symptoms % 6.8 24.3 5.5 20.7 63.1 31.7 7.1 32.4 69.4 18.8 4.6 9.7 59.6 19.3 4.1 14.3 52.0
Motor diagnosis % 0.0 4.2 1.4 6.1 8.7 7.7 2.7 13.5 12.5 1.4 0.0 0.0 5.8 2.3 2.0 0.0 4.0

Age, education, Mini-Mental State Examination (MMSE) and clinical rating scale scores are shown as mean (standard deviation)